One page, thousands of outlets. See who else covered it.
"Long sleep duration is more uncommon at mid-life than short sleep duration," the study lead told Newsweek:
We haven't written up this one. Newsweek has the full story — the link below goes straight to it.
Plus news about BioArctic, Enveda, Georgiamune, Kynexis, Tolerance Bio and Network Bio. Amgen puts the "can" in TScan: Amgen is terminating its partnership with TScan Therapeutics, the Waltham…
Republicans are heavily scrutinizing the handling of the pandemic.
In a systematic review, researchers evaluated previously published studies of Lenke type 5 adolescent idiopathic scoliosis to examine the use of PCOs in combination with PSF and compare radiographic…
In the amylin race, drug design appears to be a key differentiator. Later this year, Novo Nordisk’s CagriSema is likely to become the first approved drug containing an amylin analog and a GLP-1…
An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the…
Queen Camilla candidly discusses the emotional challenges of keeping King Charles III's cancer diagnosis private, revealing how it affected her during a recent charity visit.
